Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.
Livingstone TavulMoses LamanCade HowardBethuel KottyAnna SamuelCatherine BjerumKobie O'BrianSteven KumaiMatthew AmugaLina LorryZebedee KerryMelvin KualawiStephan KarlLeo MakitaLucy N JohnSibauk BiebJames WangiGary J WeilCharles W GossDaniel J TischWilliam PomatChristopher L KingLeanne J RobinsonPublished in: PLoS neglected tropical diseases (2022)
Registration number NCT02899936; https://clinicaltrials.gov/ct2/show/NCT02899936.